Literature DB >> 6137784

Changes in hippocampal immunoreactive dynorphin and neoendorphin content following intra-amygdalar kainic acid-induced seizures.

W Lason, B Przewlocka, L Stala, R Przewlocki.   

Abstract

Kainic acid (KA) injected focally into the amygdala induced spontaneous recurrent motor seizures. One to 6 hr after the injection of KA, the hippocampal ir-dynorphin (ir-DYN) was significantly lowered whereas 24 hr after the injection it increased. The hippocampal level of ir-alpha-neoendorphin decreased 6 hr after KA injection, and reached the control level 24 hr after the injection. Chlordiazepoxide (5 mg/kg) and phenobarbital (40 mg/kg) blocked convulsions as well as the increase in the ir-DYN content. Cycloheximide (500 micrograms icv) also antagonized the increase in the hippocampal ir-DYN. The above findings suggest that hippocampal dynorphin-related peptides are released during the seizures and that these peptides may play a physiological role in the seizure phenomena and limbic excitability.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137784     DOI: 10.1016/0143-4179(83)90028-8

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  4 in total

1.  Developmental and regional alteration of kappa-opioid receptors in seizure-susceptible EL mouse brain.

Authors:  T Kai; H Onishi; S Koide; M Katayama; S Yamagami
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

2.  Alteration of opioid receptors in seizure-susceptible El mouse brain.

Authors:  H Onishi; T Soma; S Yamagami; Y Kawakita
Journal:  Neurochem Res       Date:  1989-01       Impact factor: 3.996

Review 3.  Gene expression profiling of seizure disorders.

Authors:  Robert C Elliott; Daniel H Lowenstein
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

4.  Differences in ME-LI and VIP-LI in discrete brain regions of seizure-naive and seizure-experienced El mice.

Authors:  T Kanamatsu; S Hirano
Journal:  Neurochem Res       Date:  1988-10       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.